Michael I. D’Angelica, MD

Enid A. Haupt Chair in Surgery
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, United States

Presentation(s):

• 27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases

  Thursday, March 23, 2023
  11:16 AM – 11:26 AM

  Disclosure information not submitted.

• 37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study

  Thursday, March 23, 2023
  10:16 AM – 10:26 AM

  Disclosure information not submitted.

• 35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome

  Friday, March 24, 2023
  3:46 PM – 3:58 PM

  Disclosure information not submitted.

• 52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.

  Saturday, March 25, 2023
  10:56 AM – 11:06 AM

  Disclosure information not submitted.